Combined Therapy With a Sulfonylurea Plus Evening Insulin: Safe, Reliable, and Becoming Routine

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme

• Publication date

  1996-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/s-2007-979832PMID 8911978
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Diabetes Control and Complications Trial

  1998cited by this paper
• Safety and Efficacy of Normalizing Fasting Glucose With Bedtime NPH Insulin Alone in NIDDM

  1995cited by this paper
• Comparison of Insulin With or Without Continuation of Oral Hypoglycemic Agents in the Treatment of Secondary Failure in NIDDM Patients

  1995cited by this paper
• Bedtime Insulin/Daytime Glipizide: Effective Therapy for Sulfonylurea Failures in NIDDM

  1995cited by this paper
• Comparison of Bedtime NPH or Preprandial Regular Insulin Combined With Glibenclamide in Secondary Sulfonylurea Failure

  1995cited by this paper
• Hyperglycemie and Microvascular and Macrovascular Disease in Diabetes

  1995cited by this paper
• Comparison of Morning or Bedtime Insulin With and Without Glyburide in Secondary Sulfonylurea Failure

  1993cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Combination Therapy in NIDDM

  1993cited by this paper
• Is Combination Sulfonylurea and Insulin Therapy Useful in NIDDM Patients?: A metaanalysis

  1992cited by this paper
• Combination therapy in NIDDM.

  1992cited by this paper
• Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus.

  1992cited by this paper
• Combined therapy for obese type 2 diabetes: suppertime mixed insulin with daytime sulfonylurea.

  1992cited by this paper
• Insulin plus a sulfonylurea agent for treating type 2 diabetes.

  1991cited by this paper
• Combination of insulin and sulfonylureas: a literature review.

  1991cited by this paper
• Evening Insulin Strategy

  1990cited by this paper
• Combination Insulin-Sulfonylurea Therapy

  1990cited by this paper
• Combined Insulin-Sulfonylurea Therapy in Treatment of NIDDM

  1990cited by this paper
• Combination Therapy With Insulin and Sulfonylureas for Type II Diabetes

  1990cited by this paper
• Insulin Use in NIDDM

  1990cited by this paper
• Low-Dose Bedtime NPH Insulin in Treatment of Secondary Failure to Glyburide

  1989cited by this paper
• Efficacy of Bedtime NPH Insulin With Daytime Sulfonylurea for Subpopulation of Type II Diabetic Subjects

  1989cited by this paper
• Bedtime Insulin for Suppression of Overnight Free–Fatty Acid, Blood Glucose, and Glucose Production in NIDDM

  1989cited by this paper
• Effect of Glyburide on Glycemic Control, Insulin Requirement, and Glucose Metabolism in Insulin-Treated Diabetic Patients

  1987cited by this paper
• Natural history of diabetes presenting age 40-69 years: a prospective study of the influence of intensive dietary therapy.

  1986cited by this paper
• New tactics for type 2 diabetes: regimens based on intermediate-acting insulin taken at bedtime.

  1985cited by this paper
• Tolbutamide does not alter insulin requirement in Type 1 (insulin-dependent) diabetes

  1984cited by this paper
• Sulfonylureas Do Not Affect Insulin Binding or Glycemic Control in Insulin-dependent Diabetics

  1982cited by this paper
• Increased insulin sensitivity and cellular insulin binding in obese diabetics following treatment with glibenclamide.

  1979cited by this paper
• Appraisal of the extrapancreatic actions of sulfonylureas.

  1969cited by this paper

• Exploring the Therapeutic Potential of Xanthones in Diabetes Management: Current Insights and Future Directions

  2024cites this paper
• A Review on Invitro Evolution of Glimepiride Tablets

  2023cites this paper
• Evolving Trends in Type 2 Diabetes Management: Therapeutic Approaches for the Patients

  2021cites this paper
• Simple techniques to study multifaceted diabesity in the fly model

  2019cites this paper
• Convergence on the Constraints and Challenges in the Awareness, Prevention, Treatment and CONTROL OF TYPE 2 DIABETES and Diabetes-Related Conditions

  2018cites this paper
• Recent Trends in Therapeutic Approaches for Diabetes Management: A Comprehensive Update

  2015cites this paper
• A New Era in Diabetic Agents: Hope for Diabetics

  2012cites this paper
• The Role of Sulphonylureas in the Management of Type 2 Diabetes Mellitus

  2012cites this paper
• Modern antihyperglycemic therapy: safety and efficacy of glimepiride

  2012cites this paper
• Glimepiride: evidence-based facts, trends, and observations

  2012cites this paper
• The role of glimepiride in the treatment of type 2 diabetes mellitus

  2010cites this paper
• Cost-effective management of hyperglycemia in patients with type 2 diabetes using oral agents.

  2004cites this paper
• The role of glimepiride in the effective management of Type 2 diabetes.

  2004cites this paper
• Glimepiride in type 2 diabetes mellitus: a review of the worldwide therapeutic experience.

  2003cites this paper
• A community based approach to glucose optimisation for type 2 diabetes

  2003cites this paper
• The pathophysiologic basis of efficacy and clinical experience with the new oral antidiabetic agents.

  2002cites this paper
• Effect of glimepiride on insulin-stimulated glycogen synthesis in cultured human skeletal muscle cells: a comparison to glibenclamide.

  2002cites this paper
• Gliclazide and bedtime insulin are more efficient than insulin alone for type 2 diabetic patients with sulfonylurea secondary failure.

  2001cites this paper
• Clinical review of glimepiride

  2001cites this paper
• Pathophysiology and pharmacological treatment of insulin resistance.

  2000cites this paper
• Pharmacotherapy of Type 2 Diabetes Mellitus

  2000cites this paper
• [Present status in the treatment of type 2 diabetes mellitus. Insulin-secreting agents].

  1999cites this paper
• The use of insulin alone and in combination with oral agents in type 2 diabetes.

  1999cites this paper
• Overview of current therapeutic options in type 2 diabetes. Rationale for combining oral agents with insulin therapy.

  1999cites this paper
• Drug Therapy for Type 2 Diabetes

  1999cites this paper
• Glimepiride

  1998cites this paper
• Treatment of type 2 diabetes mellitus.

  1998cites this paper
• Glimepiride: Role of a New Sulfonylurea in the Treatment of Type 2 Diabetes Mellitus

  1998cites this paper
• Clinical trials with glimepiride.

  1998cites this paper
• Troglitazone Use in Insulin-Treated Type 2 Diabetic Patients

  1998cites this paper
• Tactics for type II diabetes.

  1997cites this paper
• New therapeutic approaches to non-insulin-dependent diabetes mellitus.

  1997cites this paper